StonvexLoading…
StonvexStonvexStonvexCore line items from AMAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-13 | Q2 2026 2026-04-26 | Q1 2026 2026-01-25 | Annual 2025 2025-10-26 | Q3 2025 2025-07-27 |
|---|---|---|---|---|---|
Revenue | $9.16B | $14.92B | $7.01B | $28.37B | $21.57B |
Operating Income | Not available | $4.35B | $1.83B | $8.29B | $6.58B |
Net Income | Not available | $4.83B | $2.03B | $7.00B | $5.10B |
EPS (Diluted) | $3.46 | $6.05 | $2.54 | $8.66 | $6.29 |
Total Assets | Not available | $40.29B | $37.64B | $36.30B | $34.21B |
Total Liabilities | Not available | $16.38B | $15.93B | $15.88B | $14.71B |
Cash & Equivalents | Not available | $6.30B | $7.22B | $7.24B | $5.38B |
Free Cash Flow OCF − CapEx | Not available | $1.25B | $1.04B | $5.70B | $3.65B |
Shares Outstanding | Not available | 799.00M | 799.00M | 793.00M | 811.00M |